Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders.
Atiq F, Saes JL, Punt MC, van Galen KPM, Schutgens REG, Meijer K, Cnossen MH, Laros-Van Gorkom BAP, Peters M, Nieuwenhuizen L, Kruip MJHA, de Meris J, van der Bom JG, van der Meer FJM, Fijnvandraat K, Kruis IC, van Heerde WL, Eikenboom HCJ, Leebeek FWG, Schols SEM; WiN, RBiN and TiN study groups. Atiq F, et al. Among authors: schols sem. EClinicalMedicine. 2021 Jan 29;32:100726. doi: 10.1016/j.eclinm.2021.100726. eCollection 2021 Feb. EClinicalMedicine. 2021. PMID: 33554093 Free PMC article.
Hemorrhagic disorders of fibrinolysis: a clinical review.
Saes JL, Schols SEM, van Heerde WL, Nijziel MR. Saes JL, et al. Among authors: schols sem. J Thromb Haemost. 2018 May 30. doi: 10.1111/jth.14160. Online ahead of print. J Thromb Haemost. 2018. PMID: 29847021 Free article. Review.
Is pharmacokinetic-guided dosing of desmopressin and von Willebrand factor-containing concentrates in individuals with von Willebrand disease or low von Willebrand factor reliable and feasible? A protocol for a multicentre, non-randomised, open label cohort trial, the OPTI-CLOT: to WiN study.
Heijdra JM, Al Arashi W, de Jager NCB, Cloesmeijer ME, Bukkems LH, Zwaan CM, Leebeek FWG, Mathôt RAA, Cnossen MH; OPTI-CLOT Study Group. Heijdra JM, et al. BMJ Open. 2022 Feb 15;12(2):e049493. doi: 10.1136/bmjopen-2021-049493. BMJ Open. 2022. PMID: 35168962 Free PMC article.
Platelet degranulation and bleeding phenotype in a large cohort of Von Willebrand disease patients.
Swinkels M, Atiq F, Bürgisser PE, van Moort I, Meijer K, Eikenboom J, Fijnvandraat K, van Galen KPM, de Meris J, Schols SEM, van der Bom JG, Cnossen MH, Voorberg J, Leebeek FWG, Bierings R, Jansen AJG; WiN study group. Swinkels M, et al. Among authors: schols sem. Br J Haematol. 2022 May;197(4):497-501. doi: 10.1111/bjh.18145. Epub 2022 Mar 22. Br J Haematol. 2022. PMID: 36165954 Free PMC article.
Desmopressin testing in von Willebrand disease: Lowering the burden.
Heijdra JM, Atiq F, Al Arashi W, Kieboom Q, Wuijster E, Meijer K, Kruip MJHA, Leebeek FWG, Cnossen MH; OPTI‐CLOT Study Group. Heijdra JM, et al. Res Pract Thromb Haemost. 2022 Sep 26;6(6):e12784. doi: 10.1002/rth2.12784. eCollection 2022 Aug. Res Pract Thromb Haemost. 2022. PMID: 36186107 Free PMC article.
High prevalence of postpartum hemorrhage in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study.
Maas DPMSM, Saes JL, Blijlevens NMA, Cnossen MH, den Exter PL, van der Heijden OWH, Kruis IC, Meijer K, Peters M, Schutgens REG, van Heerde WL, Nieuwenhuizen L, Schols SEM; RBiN study group. Maas DPMSM, et al. Among authors: schols sem. J Thromb Haemost. 2023 Mar;21(3):499-512. doi: 10.1016/j.jtha.2022.11.009. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696205 Free article.
74 results